Horizon Pharma Plc (HZNP)

18.85
0.40 2.08
NASDAQ : Health Technology
Prev Close 19.25
Open 19.22
Day Low/High 18.57 / 19.37
52 Wk Low/High 11.17 / 21.25
Volume 965.80K
Avg Volume 1.39M
Exchange NASDAQ
Shares Outstanding 166.63M
Market Cap 3.20B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

PEOPLE And Great Place To Work® Name Horizon Pharma Plc To 2018 "50 Companies That Care" List

PEOPLE And Great Place To Work® Name Horizon Pharma Plc To 2018 "50 Companies That Care" List

Horizon Pharma plc (Nasdaq: HZNP) today announced that the company has been named to PEOPLE's "50 Companies That Care " list for 2018.

Horizon Pharma Plc Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering RAVICTI® (glycerol Phenylbutyrate) Oral Liquid

Horizon Pharma Plc Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering RAVICTI® (glycerol Phenylbutyrate) Oral Liquid

Horizon Pharma plc (Nasdaq: HZNP) today announced that it has received two Notices of Allowance from the United States Patent and Trademark Office for U.

Horizon Pharma Plc To Release Second-Quarter 2018 Financial Results and Host Webcast On August 8, 2018

Horizon Pharma Plc To Release Second-Quarter 2018 Financial Results and Host Webcast On August 8, 2018

Horizon Pharma plc (Nasdaq: HZNP) announced today that its second-quarter financial results will be released on Wednesday, August 8, 2018.

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

These names are showing bullish and bearish technical patterns over the past week.

Horizon Pharma Gift Establishes First Clinical Team Endowment At Children's National Rare Disease Institute

Horizon Pharma Gift Establishes First Clinical Team Endowment At Children's National Rare Disease Institute

The endowment will support a clinical care team dedicated to providing rare disease patients with earlier intervention and more consistent treatment over the course of their lifetimes

First Week of HZNP May 18th Options Trading

First Week of HZNP May 18th Options Trading

Investors in Horizon Pharma plc saw new options begin trading this week, for the May 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 98 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

While Donald Trump's tweets can shake up pharmaceutical stocks, history suggests that investors have little to fear from the president's drug pricing rhetoric.

Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative (MEDI4945) From MedImmune

Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative (MEDI4945) From MedImmune

Agreement Aims to Further Expand Growing Gout Franchise 

TheStreet Quant Rating: D+ (Sell)